.jpg)
Recommended
June 16, 2025
EMA Identifies Rare Risk of Vision Loss with Semaglutide-Based Therapies
The European Medicines Agency’s (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) has concluded a comprehensive review of semaglutide-containing medications following growing concerns about a potential link to vision loss.
Breaking News
ViGeneron Rebrands as VeonGen, Earns FDA RPDD for Gene Therapy
Jun 16, 2025
VeonGen Therapeutics has officially announced its rebranding from ViGeneron, marking a strategic transformation into a clinical-stage genetic medicine company dedicated to developing innovative gene therapies for diseases with high unmet medical needs.
FDA Approves Amneal’s Prednisolone Acetate Ophthalmic Suspension for Steroid-Responsive Ocular Inflammation
Jun 13, 2025
Amneal Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) has approved its prednisolone acetate ophthalmic suspension, 1%, a sterile topical anti-inflammatory agent intended for steroid-responsive ocular inflammation.
European Commission Approves Ryjunea for Slowing Progression of Pediatric Myopia
Jun 10, 2025
The European Commission (EC) has granted marketing authorization for Ryjunea (SYD-101), Sydnexis’ proprietary low-dose atropine formulation.
.jpg)
Industry News
New Handheld Device Enhances Early Detection and Treatment of Amblyopia
Jun 17, 2025
Researchers at the University of Missouri–St. Louis (UMSL) have developed a groundbreaking handheld device designed to improve the early detection and treatment of amblyopia.
Heidelberg Engineering Launches ZinserLab to Drive Innovation in Ophthalmic Imaging
Jun 17, 2025
Heidelberg Engineering has officially announced the launch of ZinserLab, an innovation hub dedicated to accelerating the development of clinically valuable imaging technologies for eye care.
FDA Clears Ocugen to Launch Phase 2/3 Confirmatory Trial of OCU410ST for Stargardt Disease
Jun 17, 2025
Ocugen has received clearance from the U.S. Food and Drug Administration (FDA) to initiate a Phase 2/3 pivotal confirmatory trial of OCU410ST, following approval of an Investigational New Drug (IND) amendment.
Ophthalmic Research News
Study Links Primary Open-Angle Glaucoma Diagnosis to Decline in Mental Health Scores
Jun 12, 2025
A recent study published in JAMA Ophthalmology reveals that a diagnosis of primary open-angle glaucoma (POAG) is associated with a measurable decline in mental health scores.
European Stroke Organization Issues First International Guideline for Visual Impairment Post-Stroke
Jun 03, 2025
A new international clinical guideline led by Professor Fiona Rowe of the University of Liverpool has been released to address the diagnosis and management of visual impairment in stroke survivors.
Genetic Research Offers New Hope for Patients with Inherited Retinal Diseases
Jun 02, 2025
Researchers at the University of Oklahoma are advancing the understanding of inherited retinal diseases (IRDs) through genetic mapping that may lead to more accurate diagnoses and lay the groundwork for future treatments.
Ophthalmic Blog
AI in Ophthalmology: Top Artificial Intelligence Tools Transforming Eye Health
Mar 07, 2025
The AI in ophthalmology sector is evolving rapidly, introducing Artificial Intelligence tools in ophthalmology that enhance diagnostic accuracy, efficiency, and accessibility.
2024 Recap: Top 8 Groundbreaking Innovations in Eye Disease Therapies and Technologies
Dec 23, 2024
The year 2024 has been a remarkable period for advancements in ophthalmology, with groundbreaking innovations reshaping the landscape of eye disease treatment and diagnosis.
2024 Recap: Top 8 FDA Approvals in Ophthalmology
Dec 16, 2024
The year 2024 has been a pivotal one for ophthalmology, with several novel FDA approvals introducing innovative treatments and technologies to the field
Ophthalmology Breaking News Subscribe